SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kwality Pharma - Quaterly Results

11 Aug 2025 Evaluate
The sales for the June 2025 quarter moved up 39.21% to Rs. 1114.79 millions as compared to Rs. 800.79 millions during the corresponding quarter last year.Good  Net Profit growth of 42.62% reported above the corresponding previous quarter figure of Rs. 83.67 millions to Rs. 119.33 millioins.Operating profit surged to 245.61 millions from the corresponding previous quarter of 176.35 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 1114.79 800.79 39.21 1114.79 800.79 39.21 3701.97 3071.72 20.52
Other Income 3.76 2.78 35.25 3.76 2.78 35.25 19.20 18.30 4.92
PBIDT 245.61 176.35 39.27 245.61 176.35 39.27 823.64 684.63 20.30
Interest 27.60 24.78 11.38 27.60 24.78 11.38 98.78 103.87 -4.90
PBDT 218.01 151.57 43.83 218.01 151.57 43.83 724.86 509.77 42.19
Depreciation 47.60 40.19 18.44 47.60 40.19 18.44 182.58 195.11 -6.42
PBT 170.41 111.38 53.00 170.41 111.38 53.00 542.28 314.66 72.34
TAX 51.08 27.71 84.34 51.08 27.71 84.34 143.38 74.83 91.61
Deferred Tax 7.49 -0.32 -2440.63 7.49 -0.32 -2440.63 -15.89 -4.37 263.62
PAT 119.33 83.67 42.62 119.33 83.67 42.62 398.90 239.83 66.33
Equity 103.76 103.76 0.00 103.76 103.76 0.00 103.76 103.76 0.00
PBIDTM(%) 22.03 22.02 0.04 22.03 22.02 0.05 22.25 22.29 -0.18

Kwality Pharma Share Price

1650.00 -14.30 (-0.86%)
21-Apr-2026 10:50 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.10
Dr. Reddys Lab 1223.40
Cipla 1232.65
Zydus Lifesciences 932.25
Lupin 2327.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×